Q1 2025 Redcare Pharmacy NV Earnings Call Transcript
Key Points
- Redcare Pharmacy NV (SHPPF) reported a 28% increase in group sales, reaching EUR717 million in Q1 2025, driven by strong e-Rx growth.
- The company achieved a return to positive EBITDA, reaching 1.3% in Q1 2025, marking a 2%-point improvement from the previous quarter.
- Redcare Pharmacy NV (SHPPF) added 4.6 million active customers in Q1 2025, primarily driven by e-Rx, bringing the total to 13.1 million active customers.
- The company successfully executed two concurrent transactions, including the placement of a new convertible bond, securing financial stability for the coming years.
- Redcare Pharmacy NV (SHPPF) confirmed its full-year guidance for 2025, expecting total sales growth in excess of 25% and adjusted EBITDA between 2% and 2.5%.
- The Net Promoter Score (NPS) decreased from 70 to 64, attributed to the influx of new customers and challenges in the RX and marketplace segments.
- Despite the positive growth, the gross profit margin remained stable year-over-year, indicating limited margin expansion.
- Marketing efficiency concerns were raised, with incremental marketing spend per revenue dollar increasing since last year.
- The company faces seasonality challenges, with market share fluctuations observed during holiday periods like Christmas and Easter.
- There is uncertainty regarding the impact of potential regulatory changes in RX remuneration, which could affect future financial performance.
Ladies and gentlemen. Welcome to the Redcare Q1 2025 earnings release analyst at Investor Corp. I'm more the Coles call operator. I would like to remind you that all participants will be in a listen-only mode and the conference is being recorded. (Operator Instructions) Conference must not be recorded for publication or broadcast. Your presenters today are CEO Olaf Heinrich and CFO Jasper Eenhorst.
At this time, it's my pleasure to hand over to Monica Ambrosi. Please go ahead.
Good morning. This is just a reminder that if you should have an issue accessing the webcast, you should please go to our website to find the link under the events and publications page and webcast recording.
Thank you. Over to Olaf.
Yes, thank you very much, Monica, and hello to everybody. Very warm welcome from my side. Sorry if there are any inconvenience with the with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
